These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10480512)

  • 1. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.
    Dyck PJ; Davies JL; Wilson DM; Service FJ; Melton LJ; O'Brien PC
    Diabetes Care; 1999 Sep; 22(9):1479-86. PubMed ID: 10480512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes.
    Dyck PJ; Davies JL; Clark VM; Litchy WJ; Dyck PJ; Klein CJ; Rizza RA; Pach JM; Klein R; Larson TS; Melton LJ; O'Brien PC
    Diabetes Care; 2006 Oct; 29(10):2282-8. PubMed ID: 17003307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Moran CB; Marinho FS; Ferreira MT; Salles GF
    Diabetologia; 2015 Sep; 58(9):2161-8. PubMed ID: 26044207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.
    Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N
    J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS).
    Cabezas-Cerrato J
    Diabetologia; 1998 Nov; 41(11):1263-9. PubMed ID: 9833931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and prevalence of diabetic polyneuropathy: a cross-sectional study of Danish patients with type 2 diabetes.
    Gylfadottir SS; Itani M; Krøigård T; Kristensen AG; Christensen DH; Nicolaisen SK; Karlsson P; Callaghan BC; Bennett DL; Andersen H; Tankisi H; Nielsen JS; Andersen NT; Jensen TS; Thomsen RW; Sindrup SH; Finnerup NB
    Eur J Neurol; 2020 Dec; 27(12):2575-2585. PubMed ID: 32909392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between asymptomatic median mononeuropathy and diabetic polyneuropathy severity in patients with diabetes mellitus.
    Stamboulis E; Voumvourakis K; Andrikopoulou A; Koutsis G; Tentolouris N; Kodounis A; Tsivgoulis G
    J Neurol Sci; 2009 Mar; 278(1-2):41-3. PubMed ID: 19059612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes.
    Kim ES; Lee SW; Mo EY; Moon SD; Han JH
    Endocrine; 2015 Nov; 50(2):405-12. PubMed ID: 25846483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of Peripheral Neuropathy Is Associated With Progressive Thinning of Retinal Nerve Fiber Layer in Type 1 Diabetes.
    Dehghani C; Srinivasan S; Edwards K; Pritchard N; Russell AW; Malik RA; Efron N
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO234-BIO239. PubMed ID: 28828484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors.
    van de Poll-Franse LV; Valk GD; Renders CM; Heine RJ; van Eijk JT
    Diabet Med; 2002 Sep; 19(9):771-6. PubMed ID: 12207815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled study of medial arterial calcification of legs: implications for diabetic polyneuropathy.
    Moon JS; Clark VM; Beabout JW; Swee RG; Dyck PJ
    Arch Neurol; 2011 Oct; 68(10):1290-4. PubMed ID: 21987542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial Dysfunction as a Link Between Cardiovascular Risk Factors and Peripheral Neuropathy in Diabetes.
    Roustit M; Loader J; Deusenbery C; Baltzis D; Veves A
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3401-8. PubMed ID: 27399351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Macrophages and Peptidergic Fibers in the Skin of Patients With Painful Diabetic Polyneuropathy.
    Gylfadottir SS; Itani M; Kristensen AG; Tankisi H; Jensen TS; Sindrup SH; Bennett DLH; Nyengaard JR; Finnerup NB; Karlsson P
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34764216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control is related to the morphological severity of diabetic sensorimotor polyneuropathy.
    Perkins BA; Greene DA; Bril V
    Diabetes Care; 2001 Apr; 24(4):748-52. PubMed ID: 11315842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark.
    Andersen ST; Witte DR; Dalsgaard EM; Andersen H; Nawroth P; Fleming T; Jensen TM; Finnerup NB; Jensen TS; Lauritzen T; Feldman EL; Callaghan BC; Charles M
    Diabetes Care; 2018 May; 41(5):1068-1075. PubMed ID: 29487078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients.
    Hu YM; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ; Guo AS; Li JA; Su JB
    Endocrine; 2018 May; 60(2):292-300. PubMed ID: 29411305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor and expression of its receptors in patients with diabetic neuropathy.
    Kim HC; Cho YJ; Ahn CW; Park KS; Kim JC; Nam JS; Im YS; Lee JE; Lee SC; Lee HK
    Diabet Med; 2009 Dec; 26(12):1228-34. PubMed ID: 20002474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran.
    Kiani J; Moghimbeigi A; Azizkhani H; Kosarifard S
    Arch Iran Med; 2013 Jan; 16(1):17-9. PubMed ID: 23273229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group.
    Dyck PJ; Dyck PJ; Larson TS; O'Brien PC; Velosa JA
    Diabetes Care; 2000 Apr; 23(4):510-7. PubMed ID: 10857944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical screening and diagnosis of diabetic polyneuropathy: the North Catalonia Diabetes Study.
    Jurado J; Ybarra J; Romeo JH; Pou JM
    Eur J Clin Invest; 2009 Mar; 39(3):183-9. PubMed ID: 19260947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.